Peter Meintjes

Peter Meintjes is the CEO of Pacific Edge. Peter was previously the CEO of Omixon, a global diagnostics company that pioneered HLA typing by NGS in 2014. Prior to that, they were the Chief Commercial Officer at Omixon, responsible for global Sales & Marketing strategy, Management of the Sales & FAS Teams, Manufacturing Operations, and Business Development. Peter has also held the position of Director of US Operations at Omixon and Market Development Manager at Biomatters.

Some individuals on their team include Grant Gibson - CFO, Jimmy Suttie - SVP, Global Operations.